Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | AR | P10275 | 3/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28604976 | 0.98 | HTR2A (0.53) | HTR2ASLC6A4SMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL7690257 | 0.93 | ALDH1A1 (0.59) | HTR2ASLC6A4SMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL2608310 | 0.88 | HTT (0.65) | HTR2ASLC6A4SMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL28816731 | 0.86 | LTA4H (0.55) | SLC6A4SMN1; SMN2ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL232763 | 0.86 | SMN1; SMN2 (0.56) | SLC6A4SMN1; SMN2ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL16621785 | 0.86 | HTT (0.70) | HTR2ASLC6A4SMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL2321472 | 0.84 | ALDH1A1 (0.61) | SLC6A4SMN1; SMN2ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL3755350 | 0.84 | ALDH1A1 (0.53) | SLC6A4SMN1; SMN2ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL11853567 | 0.84 | FFAR1 (0.53) | HTR2ASLC6A4SMN1; SMN2ALDH1A1LMNA | |
| Ammonia Solution, Strong SCHEMBL6579940 | 0.84 | SMN1; SMN2 (0.54) | SLC6A4SMN1; SMN2ALDH1A1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12275695-B2 | Fluid catalytic cracking of p-cresol dimer into phenolic monomers and process thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2025-04-15 | — | — | US | claimed |
| US-20230202953-A1 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-06-29 | — | — | US | claimed |
| EP-0235647-B1 | PROCESS FOR THE MANUFACTURE OF 6,13-DIHYDROQUINACRIDONES AND QUINACRIDONES | BAYER AG (DE) | 1993-09-29 | — | — | EP | claimed |
| US-4812568-A | Process for the preparation of 6,13-dihydroquinacridones and quinacridones | BAYER AKTIENGESELLSCHAFT (DE) | 1989-03-14 | — | — | US | claimed |
| EP-0235647-A2 | Process for the manufacture of 6,13-dihydroquinacridones and quinacridones | BAYER AG (DE) | 1987-09-09 | — | — | EP | claimed |
| US-12275695-B2 | Fluid catalytic cracking of p-cresol dimer into phenolic monomers and process thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2025-04-15 | — | — | US | disclosed |
| WO-2024081943-A2 | TRANSPORT PROPERTY MODULATION VIA SOLVENT SPECIFIC BEHAVIOR IN CROSSLINKED NON-AQUEOUS MEMBRANES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2024-04-18 | — | — | WO | disclosed |
| US-20230202953-A1 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-06-29 | — | — | US | disclosed |
| US-20230202953-A1 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-06-29 | — | — | US | disclosed |
| US-20230202953-A1 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-06-29 | — | — | US | disclosed |
| EP-3326715-B1 | OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE | CE PHARM CO LTD (CN) | 2021-09-15 | — | — | EP | disclosed |
| CN-109212059-A | A kind of detection method of automobile leather odour component | 上海应用技术大学 | 2019-01-15 | — | — | CN | disclosed |
| WO-2003007954-A2 | SULFONYL ARYL HYDROXAMATES AND THEIR USE AS MATRIX METALLOPROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2003-01-30 | — | — | WO | disclosed |
| US-6281386-B1 | EXTRACTION; CONTERCURRENT WASHING | ATOFINA (FR) | 2001-08-28 | — | — | US | disclosed |
| US-4812568-A | Process for the preparation of 6,13-dihydroquinacridones and quinacridones | BAYER AKTIENGESELLSCHAFT (DE) | 1989-03-14 | — | — | US | disclosed |
| US-4410869-A | ISOMERIC MIXTURE OF DITOLYL ETHERS | BAYER AKTIENGESELLSCHAFT (DE) | 1983-10-18 | — | — | US | disclosed |
| EP-0045423-A1 | Process for the alpha-halogenation of possibly substituted methyl aromatics | BAYER AG (DE) | 1982-02-10 | — | — | EP | disclosed |
| EP-0008735-A1 | Process for the preparation of diphenyl ether carboxylic acids | BAYER AG (DE) | 1980-03-19 | — | — | EP | disclosed |
| US-4098816-A | HYPOGLYCEMIC AGENTS AND ANTILIPEMIC AGENTS | BEECHAM GROUP LIMITED (GB) | 1978-07-04 | — | — | US | disclosed |
| US-4042603-A | SUBSTITUTED DIBENZOFURAN OR 9-FLUORENONE FROM A DIPHENYL ETHER OR BENZOPHENONE | UBE INDUSTRIES, LTD. (JA) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202953-A1 | FLUID CATALYTIC CRACKING OF P-CRESOL DIMER INTO PHENOLIC MONOMERS AND PROCESS THEREOF | CAT, MCCC2, FOS | HTR2A 1410/4885SLC6A4 3285/4885SMN1; SMN2 4413/4885 |
| US-12275695-B2 | Fluid catalytic cracking of p-cresol dimer into phenolic monomers and process thereof | CAT, MCCC2, FOS | HTR2A 1410/4885SLC6A4 3285/4885SMN1; SMN2 4413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.